Riskpilot← Back to searchSign inGet full accessPLANDENT AS
ASActiveOrg 914768217Østensjøveien 27, 0661 OsloWholesale of pharmaceutical and medical goods · NACE 4646Est. 190687 employees
Revenue 2025
NOK 570,9M
+10% vs 2024
EBITDA margin
10.5%
+17% vs 2024
Equity ratio
61.1%
Financial strength
Net profit 2025
NOK 53,4M
+12% vs 2024
| Revenue | NOK 570,9M | +10% |
| EBITDA | NOK 60M | +17% |
| Net profit | NOK 53,4M | +12% |
| Total assets | NOK 435,8M | +8% |
| Equity | NOK 266,4M | +10% |
| Employees | 87 | — |
Legal name
PLANDENT AS
Org number
914768217
Legal form
Aksjeselskap
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
27. februar 1906
Share capital
NOK 10 320 000
Employees
87 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-01-31
Financial year
January – December
Company purpose
Handel med utstyr, instrumenter, forbruksmateriell og tjenester til tannleger, tannteknikere og liknende helsegrupper.
Address
Østensjøveien 27, 0661 Oslo
Phone
+4722072727
Email
post@plandent.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 276 067 | 289 927 | 300 707 | 304 195 | 341 813 | 310 206 | 308 542 | 329 755 | 319 478 | 298 496 | 329 068 | 349 662 | 378 850 | 478 225 | 511 261 | 517 751 | 570 943 |
| Staff expenses | −0 | −0 | −58 897 | −68 485 | −68 281 | −75 937 | −72 915 | −67 827 | −67 199 | −69 862 | −65 251 | −64 956 | −65 719 | −66 135 | −57 762 | −68 147 | −71 333 | −75 779 | −83 585 |
| EBITDA | 0 | 0 | 19 605 | 11 740 | 12 568 | 18 591 | 24 967 | 10 945 | 17 091 | 17 964 | 23 150 | 13 191 | 24 617 | 28 086 | 37 253 | 63 357 | 50 324 | 51 148 | 60 030 |
| Depreciation & amort. | −0 | −0 | −586 | −1 956 | −2 250 | −2 723 | −1 757 | −869 | −1 110 | −826 | −397 | −332 | −309 | −248 | −1 288 | −1 970 | −2 895 | −2 412 | −2 474 |
| EBIT | 0 | 0 | 19 019 | 9 784 | 10 318 | 15 867 | 23 210 | 10 076 | 15 981 | 17 138 | 22 754 | 12 859 | 24 308 | 27 839 | 35 965 | 61 388 | 47 429 | 48 736 | 57 556 |
| Net financials | 0 | 0 | −2 208 | 5 427 | 728 | 1 253 | 1 747 | 19 896 | 2 212 | 1 652 | 106 553 | 7 364 | 4 459 | 1 020 | 5 815 | 7 858 | 6 962 | 10 593 | 8 874 |
| Profit before tax | 0 | 0 | 16 811 | 15 212 | 11 047 | 17 121 | 24 957 | 29 972 | 18 193 | 18 791 | 129 307 | 20 223 | 28 767 | 28 859 | 41 781 | 69 245 | 54 391 | 59 329 | 66 430 |
| Tax | −0 | −0 | 4 781 | 4 385 | 3 012 | 4 627 | 2 749 | 4 224 | 4 865 | 4 848 | 6 754 | 3 465 | 5 584 | 6 341 | 7 638 | 13 696 | 10 431 | 11 516 | 13 071 |
| Net profit | 0 | 0 | 12 030 | 10 826 | 8 035 | 12 494 | 22 207 | 25 748 | 13 328 | 13 943 | 122 553 | 16 758 | 23 184 | 22 518 | 34 143 | 55 550 | 43 960 | 47 813 | 53 359 |
| Item | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | — | — | 153 357 | 150 712 | 158 835 | 173 554 | 175 245 | 194 226 | 183 235 | 200 725 | 218 818 | 201 995 | 214 364 | 278 158 | 310 830 | 356 651 | 369 446 | 404 594 | 435 786 |
| Equity | — | — | 88 381 | 88 207 | 91 242 | 95 736 | 91 549 | 110 297 | 116 625 | 120 567 | 108 120 | 114 878 | 128 061 | 150 579 | 169 722 | 195 272 | 217 232 | 243 045 | 266 405 |
| Long-term debt | 0 | 0 | 1 163 | 1 347 | 851 | 2 | 0 | 0 | 0 | 0 | 7 000 | 7 000 | 4 561 | 58 031 | 52 403 | 42 214 | 36 585 | 37 047 | 28 627 |
| Short-term debt | 0 | 0 | 61 661 | 59 144 | 65 039 | 76 827 | 77 062 | 75 263 | 66 610 | 80 158 | 103 697 | 80 117 | 81 742 | 69 547 | 88 706 | 119 165 | 115 628 | 124 502 | 140 754 |
| Total debt | 0 | 0 | 62 824 | 60 491 | 65 890 | 76 828 | 77 062 | 75 263 | 66 610 | 80 158 | 110 697 | 87 117 | 86 302 | 127 579 | 141 108 | 161 378 | 152 214 | 161 549 | 169 382 |
EBITDA margin
10.5%
This company
15.8%
Market median
-34% vs market
20072025
Equity ratio
61.1%
This company
38.2%
Market median
+60% vs market
20072025
Return on equity
20.0%
This company
18.4%
Market median
+9% vs market
20072025
Net profit margin
9.3%
This company
8.1%
Market median
+15% vs market
20072025
Asset turnover
1.31×
This company
1.12×
Market median
+17% vs market
20072025
Debt / equity
0.64×
This company
0.62×
Market median
+3% vs market
20072025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2024-02-01 – 2025-01-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2023-02-01 – 2024-01-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2022-02-01 – 2023-01-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2021-02-01 – 2022-01-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2020-02-01 – 2021-01-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2019-02-01 – 2020-01-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2018-02-01 – 2019-01-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2017-02-01 – 2018-01-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2016-02-01 – 2017-01-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2015-02-01 – 2016-01-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2014-02-01 – 2015-01-31
- Annual report 2014Filed via Brønnøysundsregistrene · Period 2013-02-01 – 2014-01-31
- Annual report 2013Filed via Brønnøysundsregistrene · Period 2012-02-01 – 2013-01-31
- Annual report 2012Filed via Brønnøysundsregistrene · Period 2011-02-01 – 2012-01-31
- Annual report 2011Filed via Brønnøysundsregistrene · Period 2010-02-01 – 2011-01-31
- Annual report 2010Filed via Brønnøysundsregistrene · Period 2009-02-01 – 2010-01-31
- Annual report 2009Filed via Brønnøysundsregistrene · Period 2008-02-01 – 2009-01-31
- Annual report 2008Filed via Brønnøysundsregistrene · Period 2008-01-01 – 2008-12-31
- Annual report 2007Filed via Brønnøysundsregistrene · Period 2007-01-01 – 2007-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
KH Deputy Member | Deputy Member | 2025 | — | — |
JM Deputy Member | Deputy Member | 2023 | — | — |
EG Deputy Member | Deputy Member | 2022 | — | — |
DH Deputy Member | Deputy Member | 2024 | — | — |
BR Deputy Member | Deputy Member | 2019 | — | — |
KA Deputy Member | Deputy Member | 2019 | — | — |
RP Chief Executive Officer | Chief Executive Officer | 2005 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2024 | — | — | |
| Chairman | 2022 | — | — | |
| Board of Directors | 2019 | — | — | |
| Board of Directors | 2025 | — | — | |
| Board of Directors | 2023 | — | — | |
| Deputy Chairman | 2025 | — | — | |
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2023 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Planmeca Oy | Company | 100.0% | 100.0% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
PLANDENT AS 
TANNLAB ASBoard members of PLANDENT AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Karl Heikki Kyøstilæ | Deputy Member | 0 companies |
| Jorun Merete Nygaard | Deputy Member | 0 companies |
| Eline Guldbrandsen | Deputy Member | 0 companies |
| Dung Hoang Vo Nguyen | Deputy Member | 0 companies |
| Birgit Rosbach Kvalvaag | Deputy Member | 0 companies |
| Kevin Andreas Westvang Thue Berthelsen | Deputy Member | 0 companies |
| Ragnar Pettersson | Chief Executive Officer | 0 companies |
| Jon Even Haugen | Board of Directors | 0 companies |
| Cecilie Sæther | Board of Directors | 0 companies |
| Janne Allan Anttila | Chairman | 0 companies |
| Kjell Frode Otnæs | Board of Directors | 0 companies |
| Minna-Mari Hannele Ahokas | Board of Directors | 0 companies |
| Trond Pihl | Board of Directors | 0 companies |
| Jukka Olavi Kanerva | Deputy Chairman | 0 companies |
| Tuomas Olli Lokki | Board of Directors | 0 companies |
| Kenneth-K Rundhaug | Board of Directors | 0 companies |